NCT07147205

Brief Summary

To learn more about your experience participating in a virtual Meaning-Centered Psychotherapy group.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
72

participants targeted

Target at P50-P75 for not_applicable

Timeline
34mo left

Started Oct 2025

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress18%
Oct 2025Feb 2029

First Submitted

Initial submission to the registry

August 27, 2025

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 29, 2025

Completed
1 month until next milestone

Study Start

First participant enrolled

October 3, 2025

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2027

Expected
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2029

Last Updated

March 16, 2026

Status Verified

March 1, 2026

Enrollment Period

1.3 years

First QC Date

August 27, 2025

Last Update Submit

March 13, 2026

Conditions

PsychotherapyIntegrative Medicine

Outcome Measures

Primary Outcomes (1)

  • Self-report Questionnaires

    Through study completion; an average of 1 year

Study Arms (1)

Intervention with Meaning-Centered Group Psychotherapy

EXPERIMENTAL
Other: Therapy

Interventions

TherapyOTHER

MCGP will be delivered in 8 weekly sessions for 90 minutes over Zoom by a licensed doctoral level psychologist.

Intervention with Meaning-Centered Group Psychotherapy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may not qualify if:

  • Children will not be enrolled in this study.
  • Pregnant women will not be enrolled in this study.
  • Cognitively impaired subjects will not be enrolled in this study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

MD Anderson Cancer Center

Houston, Texas, 77030, United States

RECRUITING

Related Links

MeSH Terms

Interventions

Therapeutics

Study Officials

  • Elizabeth C Conti, MD

    M.D. Anderson Cancer Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Elizabeth C Conti, MD

CONTACT

7135637630ecconti@mdanderson.org

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 27, 2025

First Posted

August 29, 2025

Study Start

October 3, 2025

Primary Completion (Estimated)

February 1, 2027

Study Completion (Estimated)

February 1, 2029

Last Updated

March 16, 2026

Record last verified: 2026-03

Locations

US(1)